How the Patented Medicine Prices Review Board Contributes to Controlling Drug Prices in Canada

PMPRB Symposium, Ottawa

October 7, 2002

Click here to start


Table of Contents

How the Patented Medicine Prices Review Board Contributes to Controlling Drug Prices in Canada

Environmental Scan Survey: Concerns Raised by Stakeholders

Other Major Influences on Pharmaceuticals Management

Pharmaceuticals: Fastest Growing Component of Health Spending

Five Pillars of Patent Act - 1987

Mandate of the PMPRB

Purpose of the PMPRB (Federal Court of Appeal)

Canada’s Price Review System

Price Guidelines - Patented Drugs

Remedial Powers

NPDUIS

Ratio of Cdn to Median Int’l Prices Patented Drugs, 1987-2001

Summary of Price Trends Average Annual % Changes

R&D-to-Sales Ratios, 1988-2001

Transparency

Presentation Author

Dr. Robert. G. Elgie,
Chairperson of the Patented Medicine Prices Review Board, Canada
( http://www.pmprb-cepmb.gc.ca )


PMPRB Email

pmprb@pmprb-cepmb.gc.ca

 

PMPRB Symposium 2002, List of Presentations

http://www.pmprb.com/symposium2002/present-e.html